New GERD drug tegoprazan tested in large real-world study
Disease control
Recruiting now
This study investigates the safety and symptom-relieving effects of the drug Tegoprazan (K-CAB) in adults with gastroesophageal reflux disease (GERD). Researchers will track how well the drug reduces heartburn and acid reflux after 4 weeks of use. The study includes over 5,000 pa…
Sponsor: HK inno.N Corporation • Aim: Disease control
Last updated Jul 02, 2026 02:00 UTC